Daily Roundup

BOL.ASX CCP.ASX NEU.ASX ZIP.ASX DBO.ASX

Boom Logistics Upgrades FY26 Guidance, Secures $7M in New Contracts

Boom Logistics Limited (ASX: BOL) is having a banner year, upgrading its FY26 guidance and securing around $7 million in new contract work across the infrastructure, energy, and mining sectors. The company reported strong demand, particularly in mining, driving improved utilization and earnings visibility.

Boom's statutory EPS is expected to hit 29 cents per share, implying 31% growth on FY25, while underlying EPS is forecast to reach 32 cents, representing a 47% jump. The company's NPAT (Statutory) is tipped to land between $10.5 million and $11.5 million, with NPAT (Underlying) expected to come in at $11.9 million to $12.9 million.

The guidance upgrade reflects Boom's continued momentum, with the company well-positioned to benefit from increasing activity in transmission and renewable energy projects. Investors can look forward to further utilization and earnings growth as Boom capitalizes on this supportive backdrop.

Credit Corp Provides Market Update

Credit Corp Group Ltd (ASX: CCP) is firing on all cylinders, with its US debt buying segment driving record earnings forecasts. Strong collections growth, improved productivity, and a growing payment arrangement book have all contributed to the positive performance.

The company's Australian and New Zealand lending business is also on track for a record $425 million in lending volume for FY26, up 15% on the prior year. Credit Corp's loan book is set to end the year at a new high of around $500 million.

Alongside this operational success, Credit Corp is making strides with its AI initiatives, delivering efficiency and effectiveness gains. The company has also commenced due diligence on a potential acquisition of Humm, which could provide additional consumer point-of-sale distribution.

With these tailwinds, Credit Corp is well-positioned to deliver record earnings in FY26, setting the stage for further growth in FY27.

Neuren Pharmaceuticals Q1 2026 DAYBUE net sales up 20%

Neuren Pharmaceuticals (ASX: NEU) has reported strong first-quarter results for its partner Acadia Pharmaceuticals' DAYBUE (trofinetide) product. Q1 2026 net sales of DAYBUE reached US$101 million, a 20% increase from Q1 2025 -- the highest year-on-year growth since Q3 2024.

The new DAYBUE STIX formulation, a powder version of the drug, has also seen a positive early reception, with over 250 prescriptions written in Q1 and caregiver satisfaction exceeding 80%. A Delphi expert consensus panel recently recommended DAYBUE as part of the standard of care for Rett syndrome patients.

Acadia reaffirmed its full-year 2026 guidance for DAYBUE net sales of US$460-490 million, implying royalty income for Neuren of US$50-54 million (A$70-77 million). With the product gaining traction and new formulations driving uptake, Neuren looks set to continue benefiting from this key partnership.

Zip Provides Macquarie Conference Presentation and April Trading Update

Zip Co Limited (ASX: ZIP) is firing on all cylinders, with strong growth in its US business and continued profitability in both the US and ANZ markets. The company's differentiated and resilient customer base in the US, serving the underestimated American consumer, has driven year-on-year TTV growth above 40% for April.

Zip's AI-driven models have also delivered strong credit outcomes, with net bad debts written off, including recoveries, forecasted to be less than 1.75% of TTV in Q4 2026. In the ANZ market, Zip serves 1.9 million highly-engaged customers, representing around 10% of the Australian adult population.

The company's resilient business model continues to drive increased profitability at scale, with Q3 2026 Group highlights including a 41.5% year-on-year increase in cash EBTDA, a 22.4% increase in TTV, and a 20.2% increase in total income. Zip reconfirmed its FY26 guidance, including a Group cash EBTDA of no less than $260 million and a Group cash net transaction margin of 3.8-4.2%.

Diablo Resources Ltd Acquires High-Grade Silver Project in Utah

Diablo Resources Ltd (ASX: DBO) has made a transformational acquisition, securing an 80% interest in the Horn Silver Project, a historic high-grade silver producer located in Utah. The project hosts the historic Horn Silver Mine, which produced approximately 17 million ounces of silver at an average grade of 604 g/t Ag and 30,000 ounces of gold at 1.04 g/t Au.

The mineralization remains open at depth and along strike, with multiple drill-ready targets identified through previous exploration. The broader project area also offers substantial upside, with a district-scale silver-antimony-copper system and several untested geophysical anomalies.

Diablo plans to rapidly advance the Horn Silver Project through a focused exploration program, including initial drilling to test the interpreted extensions of the historic mine and high-priority geophysical targets. The acquisition consolidates the company's footprint in a highly prospective and historically productive mining district, complementing its existing Star Range Silver-Antimony Project.

Diablo Resources Ltd Reinstated to ASX Quotation

In other news, Diablo Resources Ltd (ASX: DBO) has been reinstated to quotation on the Australian Securities Exchange (ASX) effective immediately. The suspension of trading in DBO securities has been lifted following the release of an announcement by the company regarding a proposed material acquisition and capital raise.

The reinstatement allows DBO's shares to resume trading on the ASX. No further details about the proposed acquisition or capital raise were provided in the announcement.